CorporateHow Glenmark’s AbbVie Deal is a Masterclass in Indian Pharma's R&D AmbitionsBY Vaibhavi Ranjan
NewsGlenmark Inks Licensing Pact With Jiangsu Alphamab, 3D Medicines For Cancer DrugBY Press Trust of India